NCT02791919 2017-05-03Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid LeukemiaNational Cancer Institute (NCI)Phase 1 Withdrawn